Buscar

Mostrando ítems 1-5 de 5

Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain

2019- De Mendoza, C.; Piron, M.; Jimenez, A.; Caballero, E.; Roc, L.; [et al.]

Effectiveness, safety/tolerability of OBV/PTV/r +/- DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice - Vie-KinD study

2019- Londono, Maria-Carlota; Riveiro-Barciela, Mar; Ahumada, Adriana; Munoz-Gomez, Raquel; Roget, Merce; [et al.]

Real-world evidence of the effectiveness of ombitasvir-paritaprevir/r +/- dasabuvir +/- ribavirin in patients monoinfected with chronic hepatitis C or coinfected with human immunodeficiency virus-1 in Spain

2019- Manuel Sousa, Jose; Vergara, Mercedes; Pulido, Federico; Sanchez Antolin, Gloria; Hijona, Lander; [et al.]

Predictors of hepatitis C treatment failure after using direct-acting antivirals in people living with human immunodeficiency virus

2019- Cachay, E. R.; Mena de Cea, Alvaro; Morano Amado, Luis; Benitez, L.; Maida, I.; [et al.]

Liver-related events and mortality among elderly patients with advanced chronic hepatitis C treated with direct-acting antivirals

2019- Rodríguez Osorio, Iria; Mena de Cea, Alvaro; Meijide Miguez, Hector M; Morano Amado, Luis; Delgado Blanco, Manuel; [et al.]